Han‐Seung Park

533 total citations
43 papers, 347 citations indexed

About

Han‐Seung Park is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Han‐Seung Park has authored 43 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 8 papers in Oncology. Recurrent topics in Han‐Seung Park's work include Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Han‐Seung Park is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Acute Lymphoblastic Leukemia research (15 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Han‐Seung Park collaborates with scholars based in South Korea, Japan and United States. Han‐Seung Park's co-authors include Je‐Hwan Lee, Jung‐Hee Lee, Kyoo‐Hyung Lee, Eun‐Ji Choi, Mijin Jeon, Miee Seol, Chan‐Jeoung Park, Seongsoo Jang, Dae‐Young Kim and Young‐Ah Kang and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Medicine.

In The Last Decade

Han‐Seung Park

38 papers receiving 339 citations

Peers

Han‐Seung Park
Amandine Le Bourgeois France
Joanne Filicko-O’Hara United States
Junqing Mao China
Ioannis Politikos United States
Sandeep Nagra United Kingdom
M C Putti Italy
Radwan Massoud Lebanon
C. Faucher France
Benjamin Watkins United States
S. Fürst France
Amandine Le Bourgeois France
Han‐Seung Park
Citations per year, relative to Han‐Seung Park Han‐Seung Park (= 1×) peers Amandine Le Bourgeois

Countries citing papers authored by Han‐Seung Park

Since Specialization
Citations

This map shows the geographic impact of Han‐Seung Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Seung Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Seung Park more than expected).

Fields of papers citing papers by Han‐Seung Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Seung Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Seung Park. The network helps show where Han‐Seung Park may publish in the future.

Co-authorship network of co-authors of Han‐Seung Park

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Seung Park. A scholar is included among the top collaborators of Han‐Seung Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Seung Park. Han‐Seung Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Han‐Seung, et al.. (2025). Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy. Infection and Chemotherapy. 57(1). 168–168.
2.
Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations
3.
Choi, Eun‐Ji, Tae Joon Jun, Han‐Seung Park, et al.. (2022). Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning–Based Model Development and Validation. JMIR Medical Informatics. 10(3). e32313–e32313. 4 indexed citations
4.
Choi, Eun‐Ji, Ju Hyun Moon, Ji Yun Kim, et al.. (2022). Antileukemic activity of YPN-005, a CDK7 inhibitor, inducing apoptosis through c-MYC and FLT3 suppression in acute myeloid leukemia. Heliyon. 8(10). e11004–e11004. 4 indexed citations
5.
Choi, Eun‐Ji, Young‐Uk Cho, Eun‐Hye Hur, et al.. (2022). Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower‐risk myelodysplastic syndrome. British Journal of Haematology. 198(4). 703–712. 8 indexed citations
6.
Choi, Eun‐Ji, et al.. (2021). A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Journal of Korean Medical Science. 36(43). e306–e306. 14 indexed citations
7.
Kim, Min‐Sun, John Yang, Han‐Seung Park, et al.. (2021). Effective Management of a Patient with Acquired Coagulation Factor Inhibitors Using Therapeutic Plasma Exchange Alone. Laboratory Medicine Online. 11(3). 203–207.
8.
Choi, Eun‐Ji, Je‐Hwan Lee, Hawk Kim, et al.. (2021). Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial. International Journal of Hematology. 113(6). 851–860. 7 indexed citations
9.
Jung, Sung‐Hoon, Young Rok, Dae Sik Kim, et al.. (2020). Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Yonsei Medical Journal. 61(6). 452–452.
10.
Choi, Yunsuk, Eun‐Ji Choi, Jung‐Hee Lee, et al.. (2020). Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation. Clinical Transplantation. 35(3). e14199–e14199. 7 indexed citations
11.
Park, Han‐Seung. (2020). Current treatment strategies for Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Blood Research. 55(S1). S32–S36. 7 indexed citations
12.
Choi, Eun‐Ji, Han‐Seung Park, Sang‐Ho Choi, et al.. (2020). Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients. Clinical Infectious Diseases. 71(8). 1977–1979. 6 indexed citations
13.
Choi, Eun‐Ji, Je‐Hwan Lee, Han‐Seung Park, et al.. (2019). Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 19(5). 290–299.e3. 7 indexed citations
14.
Choi, Eun‐Ji, Je‐Hwan Lee, Han‐Seung Park, et al.. (2018). Comparison of anthracyclines used for induction chemotherapy in patients with FLT3 -ITD-mutated acute myeloid leukemia. Leukemia Research. 68. 51–56. 18 indexed citations
15.
Choi, Eun‐Ji, Je‐Hwan Lee, Han‐Seung Park, et al.. (2018). Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia. Blood. 132(Supplement 1). 2713–2713. 2 indexed citations
16.
Choi, Eun‐Ji, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2018). Treatment and clinical outcomes of patients relapsing after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. Blood Research. 53(4). 288–288. 3 indexed citations
17.
Ko, Sun-Hye, Jung‐Hee Lee, Han‐Seung Park, et al.. (2017). Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors. Leukemia & lymphoma. 59(8). 1829–1839. 1 indexed citations
18.
Lee, Kyoo‐Hyung, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2017). Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission. Biology of Blood and Marrow Transplantation. 23(9). 1555–1566. 18 indexed citations
19.
Park, Han‐Seung, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2015). Expression of JL1 Antigen in Acute Leukemia and Myelodysplastic Syndrome. Blood. 126(23). 3826–3826. 1 indexed citations
20.
Kim, Dae‐Young, Han‐Seung Park, Eun‐Ji Choi, et al.. (2015). Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression. Blood Research. 50(4). 227–227. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amandine Le Bourgeois Breakdown of academic impact, for papers by Joanne Filicko-O’Hara Breakdown of academic impact, for papers by Junqing Mao Breakdown of academic impact, for papers by Ioannis Politikos Breakdown of academic impact, for papers by Sandeep Nagra Breakdown of academic impact, for papers by M C Putti Breakdown of academic impact, for papers by Radwan Massoud Breakdown of academic impact, for papers by C. Faucher Breakdown of academic impact, for papers by Benjamin Watkins Breakdown of academic impact, for papers by S. Fürst
Rankless by CCL
2026